VIRX
Viracta Therapeutics, Inc. Common Stock
VIRX
VIRX
Delisted
VIRX was delisted on the 3rd of February, 2025.
41 hedge funds and large institutions have $9.95M invested in Viracta Therapeutics, Inc. Common Stock in 2020 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 6 increasing their positions, 10 reducing their positions, and 13 closing their positions.
Holders
41
Holders Change
-6
Holders Change %
-12.77%
% of All Funds
0.84%
Holding in Top 10
2
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-60%
% of All Funds
0.04%
New
7
Increased
6
Reduced
10
Closed
13
Calls
$45K
Puts
$14K
Net Calls
+$31K
Net Calls Change
-$26K
Top Buyers
1 |
1
Citadel Advisors
Miami,
Florida
|
$1.01M |
2 |
2
Jane Street
New York
|
$36K |
3 |
VF
3
Virtu Financial
New York
|
$23K |
4 |
4
UBS Group
Zurich,
Switzerland
|
$38K |
5 |
TRCT
5
Tower Research Capital (TRC)
New York
|
$21K |